(Q47290664)

English

Combined treatment with oral etretinate and electron beam therapy in patients with cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)

scientific article published on June 1, 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/1607416

Combined treatment with oral etretinate and electron beam therapy in patients with cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome) (English)

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

mycosis fungoides

1 reference

based on heuristic

inferred from title

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

author name string

McLean J

2

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/1607416

G. Jones

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1607416

14 October 2022

J. McLean

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1607416

14 October 2022

D. Rosenthal

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1607416

14 October 2022

J. Roberts

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1607416

14 October 2022

D. N. Sauder

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1607416

14 October 2022

language of work or name

0 references

publication date

1 June 1992

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/1607416

full work available at URL

https://api.elsevier.com/content/article/PII:0190962292701423?httpAccept=text/xml

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

https://api.elsevier.com/content/article/PII:0190962292701423?httpAccept=text/plain

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

Journal of the American Academy of Dermatology

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/1607416

26

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/1607416

6

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/1607416

960-967

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/1607416

Status report of 376 mycosis fungoides patients at 4 years: Mycosis Fungoides Cooperative Group

4

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

Cutaneous T-cell lymphoma: clinicopathological relationships, therapy and survival in ninety-two patients

6

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

Total skin electron beam irradiation for cutaneous T-cell lymphoma (mycosis fungoides).

7

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

Electron-beam therapy for mycosis fungoides: the Stanford University experience

8

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

Mycosis fungoides: management with topical nitrogen mustard

10

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma

11

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

Topical mechlorethamine therapy for early stage mycosis fungoides

13

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

Combined modality therapy for tumor stage mycosis fungoides: results of a 10-year follow-up

14

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

Treatment of cutaneous T-cell lymphoma.

16

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results

19

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides

20

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

Combined modality treatment of cutaneous T cell lymphoma: results of a 6-year follow-up

21

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

Treatment of advanced stage mycosis fungoides with bleomycin, doxorubicin, and methotrexate with topical nitrogen mustard (BAM-M)

22

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

Multiple functions of vitamin A.

23

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

Nonsurgical treatments for skin cancer: retinoids and alpha-interferon

25

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

Results of the use of vitamin A and retinoids in cutaneous malignancies

26

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

Oral retinoids in mycosis fungoides and Sézary syndrome: a comparison of isotretinoin and etretinate. A study from the Scandinavian Mycosis Fungoides Group

29

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

Combination chemotherapy with bleomycin, cyclophosphamide, prednisone and etretinate (BCPE) in advanced mycosis fungoides: a six-year experience

30

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

Treatment of cutaneous lymphoma with etretinate

32

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

Treatment of mycosis fungoides with recombinant interferon-alpha 2a2 alone and in combination with etretinate

33

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

Complete resolution of Kaposi's sarcoma with systemic etretinate therapy in a patient with mycosis fungoides

34

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

Retinoids in skin cancer and hyperproliferative skin disease

36

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

Isotretinoin and cutaneous helper T-cell lymphoma (mycosis fungoides)

37

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

[Preliminary results of Re-PUVA therapy in cutaneous T-cell lymphomas]

39

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

Oral retinoid in combination with bleomycin, cyclophosphamide, prednisone and transfer factor in mycosis fungoides

41

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

Immunological findings during treatment of multiple keratoacanthoma with etretinate

44

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

Treatment of cutaneous T-cell lymphoma (mycosis fungoides) with 13-cis-retinoic acid

47

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

Treatment of mycosis fungoides with isotretinoin

48

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

An overview of the retinoids

50

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

Etretinate. A clinician's view.

51

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

Adverse effects of retinoids

54

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

Total skin electron irradiation for mycosis fungoides: relationship between acute toxicities and measured dose at different anatomic sites

55

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

Hyperlipidaemia due to isotretinoin and etretinate: possible mechanisms and consequences

60

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

A sequential comparison of etretinate (Tigason) and isotretinoin (Roaccutane) with special regard to their effects on serum lipoproteins

61

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

Etretinate therapy causes increases in lipid levels in patients with psoriasis

63

1 reference

10.1016/0190-9622(92)70142-3

https://api.crossref.org/works/10.1016/0190-9622(92)70142-3

14 October 2022

Identifiers

10.1016/0190-9622(92)70142-3

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/1607416

1 reference

Europe PubMed Central

13 January 2018

http://europepmc.org/abstract/MED/1607416

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47290664&oldid=1750641379"